Elite 50% OFF Act now – get top investing tools Register Now!

OPKO Health, Inc.

Contributing Author

Recent Articles by OPKO Health, Inc.

Nov-19	OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference OPK GlobeNewswire
Oct-29	OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results OPK GlobeNewswire
Oct-29	OPKO Health's ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications OPK GlobeNewswire
Oct-28	OPKO Health's ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers OPK GlobeNewswire
Oct-22	OPKO Health to Report Third Quarter 2025 Financial Results on October 29 OPK GlobeNewswire
Jul-31	OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results OPK GlobeNewswire
Jul-24	OPKO Health to Report Second Quarter 2025 Financial Results on July 31 OPK GlobeNewswire
Jul-08	OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress OPK GlobeNewswire
Jun-25	OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium OPK GlobeNewswire
Jun-25	OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting OPK GlobeNewswire
Jun-09	OPKO Health's ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development OPK GlobeNewswire
May-15	OPKO Health to Participate in Two Upcoming Investor Conferences OPK GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.